Orion Oyj
OTC: ORINY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Liisa Hurme
- Employees
- 3,943
- Headquarters
- Espoo, Finland
- IPO year
- 2014
- Market cap
- $22.0B
- Website
- https://www.orion.fi
Loading ORINY…
Loading profile data…Frequently asked questions about ORINY
What does Orion Oyj (ORINY) do?
Orion Oyj is a Finnish pharmaceutical company specializing in the creation, production, and commercialization of medicines for both human and animal health, as well as the active components (APIs) essential for drug formulation. Its operations extend across Finland, the Nordic region, wider Europe, North America, and various international market...
Where does ORINY trade?
Orion Oyj (ORINY) trades on the Other OTC.
What sector is ORINY in?
Orion Oyj (ORINY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Orion Oyj?
Liisa Hurme is the chief executive officer of Orion Oyj (ORINY).
Where is Orion Oyj headquartered?
Orion Oyj is headquartered in Finland.
Does ORINY pay a dividend?
Yes — Orion Oyj (ORINY) paid a trailing twelve-month dividend of USD 0.99 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ORINY go public?
Orion Oyj (ORINY) completed its initial public offering in 2014.
Is ORINY an ADR?
Yes — ORINY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Orion Oyj reporting and dividends follow the underlying issuer.